Investment Summary |
|
|---|---|
| Date | 2021-10-22 |
| Target | Egle |
| Sector | Life Science |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 42 of 47 |
| Sector: Life Science M&A | 26 of 30 |
| Type: Venture M&A Deals | 36 of 39 |
| Country: France M&A | 4 of 4 |
| Year: 2021 M&A | 10 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-16 |
Amolyt Pharma
Ecully, France Amolyt Pharma is a clinical-stage biotechnology company, building therapeutic peptides to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma was founded in 2015 and is based in Ecully, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-30 |
HotSpot Therapeutics
Boston, Massachusetts, United States HotSpot Therapeutics is a biotechnology company focused on discovering nature’s regulatory sites to advance allosteric drug discovery. HotSpot Therapeutics was formed in 2017 and is based in Boston, Massachusetts. |
Buy | - |
